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Listeria monocytogenes is an intracellular bacterium that elicits robust CD8+ T-cell
responses. Despite the ongoing development of L. monocytogenes-based platforms as can-
cer vaccines, our understanding of how L. monocytogenes drives robust CD8+ T-cell
responses remains incomplete. One overarching hypothesis is that activation of cytosolic
innate pathways is critical for immunity, as strains of L. monocytogenes that are unable to
access the cytosol fail to elicit robust CD8+ T-cell responses and in fact inhibit optimal T-cell
priming. Counterintuitively, however, activation of known cytosolic pathways, such as the
inflammasome and type I IFN, lead to impaired immunity. Conversely, production of prosta-
glandin E2 (PGE2) downstream of cyclooxygenase-2 (COX-2) is essential for optimal L.
monocytogenes T-cell priming. Here, we demonstrate that vacuole-constrained L. monocy-
togenes elicit reduced PGE2 production compared to wild-type strains in macrophages and
dendritic cells ex vivo. In vivo, infection with wild-type L. monocytogenes leads to 10-fold
increases in PGE2 production early during infection whereas vacuole-constrained strains
fail to induce PGE2 over mock-immunized controls. Mice deficient in COX-2 specifically in
Lyz2+ or CD11c+ cells produce less PGE2, suggesting these cell subsets contribute to
PGE2 levels in vivo, while depletion of phagocytes with clodronate abolishes PGE2 produc-
tion completely. Taken together, this work demonstrates that optimal PGE2 production by
phagocytes depends on L. monocytogenes access to the cytosol, suggesting that one rea-
son cytosolic access is required to prime CD8+ T-cell responses may be to facilitate produc-
tion of PGE2.
Author summary
L. monocytogenes is an intracellular bacterial pathogen that generates robust cell-mediated
immune responses. Due to this robust induction, L. monocytogenes is used as both a
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model to understand how CD8+ T-cells are primed, as well as a platform for cancer immu-
notherapy vaccines. L. monocytogenes must enter the cytosol of an infected host cell to
stimulate robust T-cell responses, however, which cytosolic innate pathway (s) contribute
to T-cell priming remains unclear. Previous data demonstrated that COX-2-dependent
PGE2 production is critical for T-cell responses to L. monocytogenes. Here, we found that
ex vivo PGE2 production by macrophages and dendritic cells is partially dependent on
cytosolic access, as vacuole-constrained strains of L. monocytogenes elicit reduced PGE2.
In vivo, cytosolic access is essential for PGE2 production. L. monocytogenes elicits a 10-
fold increase in PGE2 production, whereas strains of L. monocytogenes that cannot access
the cytosol fail to elicit PGE2 compared to mock immunized mice. Furthermore, CD11c
+
and Lyz2+ cells contribute to PGE2 production in vivo, as mice deficient in COX-2 in
these cell subsets have impaired PGE2 production, while mice depleted of all phagocytes
by clodronate treatment are incapable of producing PGE2. Taken together, our work fur-
thers our understanding of how PGE2, a molecule critical for generating T-cell responses,
is generated during immunization with L. monocytogenes.
Introduction
Listeria monocytogenes is a Gram-positive, intracellular pathogen that elicits robust T-cell
responses. Though both CD4+ and CD8+ T-cells contribute to development of Listeria-
induced immunity, experiments involving adoptive transfers or in vivo depletion highlight the
importance of CD8+ T-cells specifically in mediating protective responses [1,2]. As such, L.
monocytogenes has been used for decades as a model to understand how CD8+ T-cell responses
are primed [3]. Understanding these responses has become more pressing recently as Listeria-
based platforms aiming to drive CD8+ T-cell responses are in clinical trials as cancer immuno-
therapies [4]. Initial work showed that critical signals promoting Listeria-stimulated T-cell
responses are provided acutely, as bacterial clearance with antibiotics as early as 24 hours-post
infection has minimal impact on the kinetics of CD8+ T-cell responses [5]. This work high-
lights the role of early signals in informing Listeria-stimulated cell mediated adaptive
responses.
One early signal impacting T-cell responses is the inflammatory environment induced dur-
ing infection. The importance of the inflammatory milieu on priming T-cell responses has
been solidified by multiple groups using antigen-pulsed, matured dendritic cells in combina-
tion with non-antigen expressing L. monocytogenes as an inflammatory boost [6,7]. These
studies enable discrimination between antigen presentation and inflammation and demon-
strate that wild-type L. monocytogenes provides an optimal inflammatory milieu to drive T-cell
priming [6,7]. The inflammatory boost provided through wild-type L. monocytogenes infection
led to increased T-cell responses, whereas use of strains that specifically alter the inflammatory
milieu led to suboptimal responses [6,7]. L. monocytogenes activates a number of innate path-
ways that contribute to the inflammatory milieu. In particular, multiple groups have focused
on the role of various cytosolic innate immune pathways, as previous research demonstrated
the necessity of cytosolic access in priming cell-mediated immunity [8–10]. L. monocytogenes
utilizes a cytolysin, listeriolysin O (LLO), to escape from phagosomes directly into the cytosol
and LLO-deficient mutants that are unable to access the cytosol inhibit T-cell priming and
generate tolerizing immune responses [11,12]. Despite the importance of cytosolic access for
priming T-cell responses, multiple cytosol-dependent innate pathways are counterintuitively
detrimental to immunity, including STING-dependent type I interferon [13,14] as well as
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inflammasome activation [6,15]. We recently identified an alternative innate pathway, produc-
tion of the eicosanoid prostaglandin E2 (PGE2), as important for immunity as mice deficient
in PGE2 have impaired acute and protective T-cell responses to L. monocytogenes [16].
Whether PGE2 production is dependent on cytosolic access of L. monocytogenes remains
unknown, as is which cells produce PGE2 in response to L. monocytogenes infection.
Eicosanoids are lipid mediators of inflammation that have potent and diverse biological
functions. A major subset of these lipids, including PGE2, are derived from arachidonic acid
[17]. During inflammation, arachidonic acid is liberated from the membrane by the cytosolic
phospholipase A2 (cPLA2) and then is further metabolized by a number of enzymes including
the P450 epoxygenase, lipoxygenases, and cyclooxygenases (COXs) [17]. During infection,
PGE2 is produced downstream of COX enzymes, particularly downstream of cyclooxygenase-
2 (COX-2) [18]. COX-2 is induced during inflammation and functions to reduce arachidonic
acid to prostaglandin H2 (PGH2) [19,20]. PGH2 is further metabolized into different prosta-
glandins by terminal prostanoid synthases. Coupling of COX enzymes with prostanoid
synthases ultimately dictates which prostaglandin will be produced [19,20]. PGE2 specifically
is produced by three different terminal synthases, the cytosolic prostaglandin E synthase
(cPGES) and microsomal prostaglandin E synthases-1 and -2 (mPGES-1 and mPGES-2)
[18,21]. Of these synthases, mPGES-1 is inducible and associated with infection due to its role
in inflammatory responses [18,21]. For example, mice deficient in mPGES-1 have reduced
febrile and pain responses [18,21]. Previously, we showed that L. monocytogenes infection of
mice deficient in mPGES-1 or use of a COX-2-specific inhibitor leads to impaired T-cell
responses that could be rescued by exogenous dosing of PGE2[16]. Together, these data suggest
that production of PGE2 downstream of COX-2 and mPGES-1 is critical for immunity.
During L. monocytogenes infection, the cell types responsible for producing PGE2 remain
unclear. L. monocytogenes is initially captured by a wide range of phagocytic antigen present-
ing cells (APCs) in the marginal zone of the spleen [22]. Initially, L. monocytogenes highly
infects multiple macrophage subsets, including MOMA+ metallophilic and MARCO+
marginal zone macrophages [22]. Later, L. monocytogenes infection transitions to splenic
CD11c+ and CD11b+ cells in the white pulp [22]. Importantly, PGE2 is produced at high
amounts early in the immune response, starting at four hours post-immunization and peaking
at twelve hours, early timepoints during which macrophages and dendritic cells are heavily
infected [16]. Furthermore, one previous study demonstrated that peritoneal macrophages are
capable of producing PGE2 after ex vivo infection with L. monocytogenes[23]. Further analysis
is required to elucidate whether macrophages and dendritic cells similarly produce PGE2 in
vivo.
Here, we demonstrated ex vivo that macrophages and dendritic cells produce PGE2 in
response to L. monocytogenes infection. Importantly, induction of PGE2 ex vivo was partially
dependent on cytosolic access, as infection of bone marrow-derived macrophages or dendritic
cells with vacuole-constrained L. monocytogenes led to reduced PGE2 compared to wild-type
strains. In contrast, in vivo PGE2 production requires cytosolic access, as infection with LLO-
deficient L. monocytogenes led to a complete lack of PGE2 induction, similar to mock-immu-
nized levels. Lyz2+ and CD11c+ cells contribute to PGE2 production in vivo, as deletion of
COX-2 selectively in these subsets led to reduced splenic PGE2 levels. However, these subsets
are not solely responsible for production as a small amount of PGE2 remains and this remain-
ing PGE2 is sufficient to facilitate optimal T-cell priming. Use of phagocyte-depleting clodro-
nate treatment completely eliminated PGE2 production to mock-immunized levels. Taken
together, we show that phagocytes, particularly macrophages and dendritic cells, produce
PGE2 in a cytosol-dependent manner.
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Results
Unprimed macrophages and dendritic cells upregulate PGE2-synthesizing
enzymes in response to cytosolic L. monocytogenes
We previously demonstrated that immunization of mice with L. monocytogenes induces pro-
duction of PGE2, starting at four hours post-infection and peaking at twelve hours, and that
this transient PGE2 production is necessary for optimal T-cell priming [16]. During infection,
L. monocytogenes infects multiple phagocytic cell populations in the spleen, the majority of
which are macrophage and dendritic cell subsets [22]. Initially, L. monocytogenes localizes to
multiple macrophage subsets [22] and by twelve hours after infection, CD11c+ dendritic cells
comprise the largest subset of L. monocytogenes infected cells [22]. We hypothesized that mac-
rophages and dendritic cells were the subsets producing PGE2 due these cells being the pre-
dominantly infected cell subsets at these early timepoints post immunization. To determine if
L. monocytogenes infection induces the genes necessary for PGE2 production, we first mea-
sured expression of Pla2g4a mRNA (encoding cPLA2), a phospholipase that releases arachi-
donic acid from the cell membrane [17], in bone marrow derived macrophages (BMDMs) and
bone marrow derived dendritic cells (BMDCs). BMDMs and BMDCs were infected with L.
monocytogenes and mRNA was harvested six hours later. We found that Pla2g4a expression
did not change during L. monocytogenes infection (S1A Fig). This result was not surprising, as
much of cPLA2 activity is modulated by calcium influx and MAPK phosphorylation rather
than transcriptional changes [24]. We next measured mRNA expression of Ptgs2 (encoding
COX-2) and Ptges (encoding mPGES-1), enzymes involved in the next steps of PGE2 synthesis
[18,21]. In both BMDMs and BMDCs, infection with wild-type L. monocytogenes led to an
increase in Ptgs2 expression and, to a lower extent, Ptges, suggesting that macrophages and
dendritic cells could be capable of synthesizing PGE2 (Fig 1A and 1B). Given that PGE2 is nec-
essary for optimal T-cell priming and that immunizing mice with a strain of L. monocytogenes
that cannot access the cytosol leads to abolished T-cell effector function [11,12], we hypothe-
sized that the lack of T-cell responses to vacuole-constrained bacteria may be partially due to
reduced expression of PGE2-synthesizing enzymes and ultimately decreased production of
PGE2. To test this hypothesis, we infected BMDMs and BMDCs with a vacuole-constrained
strain of L.monocytogenes (Δhly, a mutant lacking the pore-forming protein LLO) and assessed
expression of Ptges and Ptgs2 mRNA. Consistent with this hypothesis, infection with this strain
led to reduced Ptgs2 expression in BMDMs and BMDCs, suggesting that cytosolic access is
required for optimal expression of Ptgs2 (Fig 1A). Interestingly, infection with Δhly L. monocy-
togenes led to similar levels of Ptges expression in both BMDMs and BMDCs (Fig 1B). Taken
together, these results suggest that cytosolic access increases Ptgs2 expression in BMDMs and
BMDCs, whereas Ptges expression is induced independently of cytosolic access. Additionally,
as controls we assessed expression of Ifnb1 (encoding IFN-β) and Il1b (encoding IL-1β) in
BMDMs and BMDCs. As expected, Ifnb1 was expressed only during infection with cytosolic,
wild-type L. monocytogenes in both cell subsets (S1B Fig), where Il1b was induced by TLR sig-
naling during infection with both wild-type and Δhly L. monocytogenes infection (S1C Fig).
Given that Ptgs2 expression was higher during infection with wild-type compared to Δhly L.
monocytogenes, we next assessed whether the increased transcript in wild-type infection led to
increased COX-2 protein expression. To assess the role of cytosolic access on COX-2 protein lev-
els, we infected BMDMs or BMDCs with wild-type or Δhly L.monocytogenes and assessed COX-2
protein expression six hours later by western blot. In BMDMs, interestingly, infection with either
strain of L.monocytogenes led to increased COX-2 protein expression (Fig 1C). In BMDCs, alter-
natively, Δhly L.monocytogenes induced lower levels of COX-2 protein (Fig 1C). This suggests
that cytosolic access is required for robust induction of COX-2 protein expression in BMDCs.
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Infection of BMDMs and BMDCs with wild-type L. monocytogenes led to expression of the
genes necessary for PGE2 production (Fig 1A–1C). To assess whether these cells could utilize
these enzymes to produce PGE2, we assessed PGE2 production in culture supernatant by mass
spectrometry. Surprisingly, supernatant from both BMDMs and BMDCs had no detectable
PGE2 compared to PBS-treated controls, both during infection with wild-type or Δhly L.
monocytogenes (Fig 1D). This suggests that either enzyme expression was not high enough to
induce detectable PGE2, or there may be additional post transcriptional modifications required
for enzyme activity. Analysis of PGE2 from BMDMs or BMDCs deficient in COX-2 had no
detectable PGE2, as expected (Fig 1D).
Primed BMDMs and BMDMs produce PGE2 during cytosolic L.
monocytogenes infection
The lack of PGE2 produced by BMDMs and BMDCs in response to L. monocytogenes infection
was surprising given the upregulation of Ptgs2 and Ptges transcripts. Other innate pathways,
such as the inflammasome, require a priming step in order to induce optimal activation. We
hypothesized that naïve bone marrow-derived phagocytes may similarly require additional stim-
ulation in order to produce PGE2. To test this hypothesis, we treated BMDMs and BMDCs over-
night with the TLR2 agonist PAM3CSK4 (PAM) before infection with wild-type and Δhly L.
monocytogenes and again analyzed transcript expression. PAM alone induced a small amount of
expression of Ptgs2 expression in both BMDMs and BMDCs (Fig 1A). Infection with wild-type
L. monocytogenes led to a significant increase in expression that was less robust in Δhly L. mono-
cytogenes-infected cells, similar to the effect seen in unprimed cells (Fig 1A). Ptges expression,
alternatively, had a larger increase in transcript expression during PAM-priming, both during
wild-type and Δhly L.monocytogenes infection of BMDMs and BMDCs (Fig 1B). Furthermore,
PAM treatment alone induced expression of Ptges similar to that induced during infection in
BMDMs (Fig 1B). Taken together, these data suggest that cytosolic access accentuates expression
of Ptgs2, where TLR signaling alone is sufficient to induce Ptges expression. We also assessed
expression of Pla2g4a in TLR-primed BMDMs and BMDCs and, similar to unprimed cells, saw
no changes in expression (S1A Fig). Additionally, Ifnb1 transcript was again induced during
cytosolic infection, where Il1b expression was induced during PAM-treatment alone, as well as
during infection with wild-type or Δhly L. monocytogenes (S1B and S1C Fig).
As Ptgs2 expression was also dependent on cytosolic access in primed BMDMs and
BMDCs, we next assessed expression of COX-2 protein in primed cells infected with wild-type
or Δhly L. monocytogenes by western blot. Similar to unprimed cells, BMDMs had similar lev-
els of COX-2 protein during infection with wild-type or Δhly L. monocytogenes (Fig 1C). In
BMDCs, alternatively, COX-2 protein expression was reduced during infection with Δhly L.
monocytogenes compared to wild-type infection (Fig 1C), again suggesting that COX-2 protein
expression in BMDCs is potentiated by cytosolic access.
We hypothesized that priming BMDMs and BMDCs with PAM would stimulate the cells to
produce PGE2 during infection with wild-type L. monocytogenes. To test this hypothesis, we
Fig 1. PAM-primed BMDMs and BMDCs express PGE2 after cytosolic infection with L. monocytogenes. Wild-type or
COX-2-/- BMDMs or BMDCs were infected with indicated strains of L. monocytogenes at an MOI of 10 +/- the TLR2
agonist PAM3CSK4 and assessed 6hpi for expression of Ptgs2 (encoding COX-2) and Ptges (encoding mPGES-1) by qRT
PCR (A-B) or COX-2 protein by western blot (C). Supernatant was harvested and assessed for PGE2 by mass
spectrometry (D). Mass spectrometry data was normalized to d-PGE2 and fold change is relative to PBS treated controls.
Data are a combination of at least two independent experiments (A,B, D, and western blot quantification), or a
representative of at least two independent experiments (western blot image). Significance was determined by a one-way
ANOVA with Bonferroni’s correction. �p< 0.05, ��p< 0.01, ���p< 0.001, ����p< 0.0001.
https://doi.org/10.1371/journal.ppat.1009493.g001
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assessed production of PGE2 in the supernatant of primed BMDMs and BMDCs by mass spec-
trometry. BMDMs and BMDCs were treated overnight with PAM before infection with wild-
type and Δhly L. monocytogenes. Six hours post-infection, cell supernatant was assessed for
PGE2. In contrast to unprimed BMDM and BMDCs, wild-type infection of primed cells led to
a significant increase in PGE2 production compared to PBS-treated controls (Fig 1D). Previous
data showed L. monocytogenes-stimulated PGE2 production in peritoneal macrophages
[23,25]. Our data suggest that priming BMDMs prior to infection induces the cells to behave
more like tissue resident macrophages in respect to PGE2 production. Furthermore, the ability
of BMDMs to produce PGE2 provides a tool to efficiently study PGE2 synthesis in macro-
phages during infection. PAM-primed COX-2 deficient BMDMs and BMDCs again led to no
PGE2 production, solidifying the necessity of COX-2 activity in PGE2 production (Fig 1D). To
characterize the kinetics of PGE2 production, we analyzed PGE2 production via ELISA from
two to eight hours post-infection in BMDMs. During wild-type infection, PGE2 was produced
as early as two hours post-infection (S1D Fig). PGE2 peaked at six hours post-infection, consis-
tent with our mass spectrometry data showing elevated levels at this time point (S1D Fig).
PGE2 levels were maintained until at least eight hours post-infection (S1D Fig).
Importantly, maximal PGE2 production in primed BMDM and BMDCs was dependent on
cytosolic access, as infection with Δhly L. monocytogenes led to significantly reduced PGE2 lev-
els (Fig 1D). No PGE2 was detected during Δhly L. monocytogenes infection at any earlier or
later timepoints assessed, suggesting that vacuole-constrained infection does not simply alter
PGE2 production kinetics (S1D Fig). Furthermore, when BMDMs were infected with substan-
tially more Δhly L. monocytogenes (MOI 50 compared to MOI 10 wild-type L. monocytogenes)
there was still significantly less PGE2 production at six hours-post infection (S1E Fig). Taken
together, these results suggest that cytosolic L. monocytogenes induces robust PGE2 production
in TLR-primed BMDMs and BMDCs.
Given our data that cytosolic access potentiated PGE2 production in BMDMs and BMDCs,
we next assessed whether known cytosolic pathways influenced production of PGE2. Two
innate cytosolic pathways activated by L. monocytogenes, inflammasomes and type I IFN, can
influence PGE2 production in other infection models [25–27]. Accordingly, we assessed PGE2
production ex vivo during infection with strains of L. monocytogenes that alter activation of
these pathways. Infection of BMDMs with ΔtetR L. monocytogenes (a strain that hyperactivates
type I IFN) [28] or ΔmdrMTAC (a strain that induces less type I IFN) [29] did not alter PGE2
production (S1F Fig). In contrast, infection with a strain that hyperactivates the inflamma-
some, Lm-pyro, led to a small but reproducible decrease in PGE2 production (S1F Fig), sug-
gesting that inflammasome activation may influence PGE2 production in response to L.
monocytogenes infection.
Lastly, we also sought to understand whether PGE2 specifically was being induced, or if
there was a more broad increase eicosanoid production. To test the hypothesis that L. monocy-
togenes induces production of other eicosanoids, we analyzed production of prostaglandin D2
(PGD2), thromboxane B2 (TXB2), and leukotriene B4 (LTB4). However, we saw no changes
production of these eicosanoids by wild-type L. monocytogenes (S2A and S2B Fig). This inter-
esting observation suggests that macrophages and dendritic cells preferentially induce PGE2 in
response to infection with cytosolic L. monocytogenes.
Cytosolic access is required for PGE2 production in vivo
Production of PGE2 by TLR-primed BMDMs and BMDCs ex vivo is potentiated by cytosolic
access. To assess whether L. monocytogenes induces PGE2 in a cytosol-dependent manner in
vivo, we infected mice intravenously with wild-type and Δhly L. monocytogenes and assessed
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PGE2 levels in the spleen twelve hours post-infection, previously defined as the peak PGE2
response to infection [16]. Wild-type L. monocytogenes led to an eight-fold increase in PGE2
(Fig 2A). Infection with Δhly L. monocytogenes strikingly showed no increase in PGE2 over
mock-immunized controls (Fig 2A). To ensure that the reduced PGE2 production was not due
to differences in bacterial burdens, mice were infected at a dose of wild-type (105 bacteria) and
Δhly L. monocytogenes (107 bacteria) that led to comparable burdens (Fig 2B). This shows that
the absence of PGE2 in Δhly L.monocytogenes-infected mice is not just due to reduced bacterial
burdens. Taken together, these data highlight that cytosolic access is necessary for in vivo
induction of PGE2.
Previous data demonstrated that infection with Δhly L. monocytogenes fails to induce robust
cell-mediated immunity [11,12]. Furthermore, coinfection of Δhly L. monocytogenes with
wild-type L. monocytogenes suppresses T-cell priming associated with wild-type infection,
demonstrating that infection with vacuole-constrained L. monocytogenes induces an immuno-
suppressive environment [11]. We hypothesized that infection with Δhly L. monocytogenes
may actively inhibit PGE2 production, contributing to impaired T-cell responses. To address
this hypothesis, we infected mice with wild-type L. monocytogenes, Δhly L. monocytogenes, or a
coinfection of both strains and assessed PGE2 levels twelve hours post-infection. Wild-type L.
monocytogenes infection induced PGE2 whereas Δhly L. monocytogenes failed to induce pro-
duction, as expected (Fig 2C). Strikingly, coinfection of the two strains led to little to no PGE2
production (Fig 2C) suggesting that vacuole-constrained strains of L. monocytogenes actively
impair production of PGE2. Active inhibition of PGE2 production, combined with the previ-
ously described impacts of TLR-dependent IL-10[11], could be one of multiple reasons why
Δhly L. monocytogenes fails to induce protective immunity.
CD11c+ and Lyz2+ cells produce PGE2 during L. monocytogenes infection in
vivo
Our data identified PGE2 production by macrophages and dendritic cells ex vivo (Fig 1D). Fur-
thermore, previous groups have reported that macrophage and dendritic cell subsets are
heavily infected early during in vivo infection, a timepoint where we have previously detected
increases in splenic PGE2 [16,22]. From these data, we next hypothesized that macrophages
and/or dendritic cells were responsible for producing PGE2 in vivo that is necessary for opti-
mal T-cell priming. Accordingly, we hypothesized that deletion of PGE2 production in these
cells specifically would 1) reduce the splenic levels of PGE2 and 2) impair the robust CD8
+ T-
cell responses normally induced by L. monocytogenes. To test these hypotheses, we generated
mice deficient in COX-2 selectively in CD11c+ cells or Lyz2+ cells using the cre/lox system.
Mice containing loxP sites flanking the COX-2-encoding gene (COX-2fl/fl) were crossed with
mice expressing the cre recombinase under the CD11c (CD11c-cre+) or Lyz2 (Lyz2-cre+) pro-
moters. COX-2fl/fl CD11c-cre+ and COX-2fl/fl Lyz2-cre+ mice were immunized with 107 CFU
of a live-attenuated, vaccine strain of L. monocytogenes (LADD L. monocytogenes) currently
used in clinical trials as a cancer therapy platform [30]. The LADD strain is deficient in two
major virulence genes, actA and inlB, but retains immunogenicity, making it safe for clinical
use [30,31]. The LADD vaccine strain was used here to enable analysis of T-cell responses in
floxed mice as discussed below and induces similar levels of PGE2 [16].
We first hypothesized that immunization of COX-2fl/fl CD11c-cre+ and/or COX-2fl/fl
Lyz2-cre+ mice with LADD L. monocytogenes would lead to lower levels of splenic PGE2 com-
pared to control mice. Immunization of COX-2fl/fl CD11c-cre+ and COX-2fl/fl Lyz2-cre+ mice
each showed reduced levels of PGE2 production, leading to only 60% of the PGE2 induced dur-
ing immunization of control mice (Fig 3A). However, deletion of COX-2 in either CD11c+ or
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Fig 2. Cytosolic access is necessary for L. monocytogenes-stimulated PGE2 production in vivo. C57BL/6 mice were infected with 105 wild-type or 107 Δhly L.
monocytogenes. 12hpi spleens were harvested for eicosanoid extraction and mass spectrometry (A) and livers were harvested for bacterial burdens (B). C57BL/6 mice were
infected with 105 wild-type, 107 Δhly L. monocytogenes, or a combination of both strains. 12hpi spleens were harvested for eicosanoid extraction and mass spectrometry
(C). Data are representative of two independent experiments. Mass spectrometry data was normalized to d-PGE2 levels and fold change is compared to PBS controls.
Significance was determined by a one-way ANOVA with Bonferroni’s correction. ��p< 0.01, ����p< 0.0001.
https://doi.org/10.1371/journal.ppat.1009493.g002
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Lyz2+ cells did not fully abrogate production of PGE2 as observed in mice globally deficient in
mPGES-1 (mPGES-1-/-) (Fig 3A). This suggests that CD11c+ and Lyz2+ cells each contribute
to PGE2 production and that deletion of COX-2 in either is not sufficient to completely pre-
vent PGE2 production. We also assessed PGE2 levels in mice deficient in COX-2 selectively in
T-cells and PGE2 production was still observed (S3 Fig). As T-cells are not known to be
Fig 3. CD11c+ and Lyz2+ cells contribute to PGE2 production in vivo. Indicated strains of mice were infected with 107 LADD L. monocytogenes. 12hpi spleens were
harvested and assessed for PGE2 by mass spectrometry. Data was normalized to d-PGE2 levels and percent change is compared to L. monocytogenes-infected controls
(A). Indicated strains of mice were infected with 107 LADD L. monocytogenes. 7dpi splenocytes were examined for B8R-specific CD8+ T-cell responses. %IFNγ (B) or
number IFNγ (C) per spleen was assessed. Data shown are representative of two independent experiments. Significance was determined by a one-way ANOVA with
Bonferroni’s correction (A). �p< 0.05, ��p< 0.01, ���p< 0.001.
https://doi.org/10.1371/journal.ppat.1009493.g003
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infected by L. monocytogenes, this is consistent with our hypothesis suggesting PGE2 produc-
tion specifically from infected cell subsets.
PGE2 is critical for generating optimal T-cell responses in response to L. monocytogenes, as
immunization of mPGES-1-deficient mice or treatment of mice with a COX-2-specific phar-
macological inhibitor leads to impaired CD8+ T-cell responses [16]. We next hypothesized
that the decreased PGE2 production in the COX-2
fl/fl CD11c-cre+ or COX-2fl/fl Lyz2-cre+ mice
would be sufficient to similarly impair CD8+ T-cell responses. We specifically assessed the
impact on CD8+ T-cells as these are the predominate cells contributing to protective immunity
to L. monocytogenes [1,2] and are cells of interest in L. monocytogenes-based cancer immu-
notherapeutics [4]. To test this hypothesis, we immunized mice with 107 LADD L. monocyto-
genes expressing the model antigens B8R and OVA. Seven days after immunization,
splenocytes were isolated, stimulated with B8R or OVA, and production of IFNγ was assessed
by flow cytometry. Despite decreased PGE2 production in these mice, T-cell responses were
not affected both in percent IFNγ+ as well as number of IFNγ+ T-cells per spleen (Figs 3B, 3C,
S4A and S4B). Similarly, the number of antigen-specific T-cells measured by B8R tetramer was
unchanged in these mice compared to control mice (S4C Fig). This suggests that the PGE2
remaining in these mice was sufficient to prime productive T-cell responses. Due to its short
in vivo half-life, PGE2 asserts its effects locally [32]. It is possible that while global splenic PGE2
levels are decreased, the local concentrations of PGE2 are sufficient to prime T-cell responses.
Taken together, these data suggest that although Lyz2+ and CD11c+ cells contribute to produc-
tion of PGE2 during L. monocytogenes infection, PGE2 production by either cell subset alone
these cells is not necessary for T-cell priming, as CD8+ T-cell responses are not impacted by
loss of PGE2 production in either subset.
Deletion of COX-2 in both Lyz2+ and CD11c+ cells further reduces splenic
PGE2 levels
Our data showed that single deletions of COX-2 in CD11c+ or Lyz2+ cells reduced PGE2, but
not to baseline values. We next hypothesized that PGE2 production by either of these subsets
individually was sufficient for T-cell priming and that to observe impaired T-cell responses we
would have to eliminate PGE2 production in both CD11c
+ and Lyz2+ cells. To do this, we
crossed the COX-2fl/fl CD11c-cre+ and COX-2fl/fl Lyz2-cre+ mice, leading to mice with a COX-
2 deletion in both cell subsets (COX-2fl/fl CD11c-cre+ Lyz2-cre+). We assessed the ability of
these mice to produce PGE2 by mass spectrometry and found that PGE2 was further reduced,
with about 40% the amount PGE2 produced compared to immunized control mice (Fig 4A).
This suggests that CD11c+ and Lyz2+ cells combined to produce the majority of PGE2 during
immunization with L. monocytogenes.
Due to further reduced PGE2 production in our mice deficient in COX-2 in both CD11c
+
and Lyz2+ cells, we next assessed CD8+ T-cell responses in these mice. Mice again were immu-
nized with 107 vaccine strain of L.monocytogenes expressing the model antigens B8R and OVA
and assessed for IFNγ production seven days later. Despite diminished PGE2 production, CD8
+
T-cell responses remained intact in the double COX-2 deficient mice, both in percent and num-
ber (Figs 4B, 4C, S5A and S5B). Similarly, antigen-specific T-cells measured by B8R tetramer
were also unchanged compared to wild-type controls (S5C Fig). This suggest that even the small
amount of PGE2 produced locally is sufficient to drive CD8
+ T-cell responses.
Depletion of phagocytes eliminates PGE2 production in vivo
Our ex vivo data highlighted the ability of BMDMs and BMDCs to produce PGE2 in response
to cytosolic L. monocytogenes. However, deletion of COX-2 in Lyz2+ and CD11c+ cells did not
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Fig 4. Deletion of COX-2 in both CD11c+ and Lyz2+ cells further reduces PGE2 production. Indicated strains of mice were infected with 10
7 LADD L.
monocytogenes. 12hpi spleens were harvested and assessed for PGE2 by mass spectrometry. Data was normalized to d-PGE2 levels and percent change is compared to
L. monocytogenes-infected controls (A). Indicated strains of mice were infected with 107 LADD L. monocytogenes. 7dpi splenocytes were examined for B8R-specific
CD8+ T-cell responses. %IFNγ (B) or number IFNγ (C) per spleen was assessed. Data shown are representative of two independent experiments of 3–5 mice per
group. Significance was determined by a one-way ANOVA with Bonferroni’s correction (A) or a Mann-Whitney U test (B-C). �p< 0.05, ��p< 0.01.
https://doi.org/10.1371/journal.ppat.1009493.g004
PLOS PATHOGENS Phagocytes produce prostaglandin E2 in response to cytosolic Listeria monocytogenes
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009493 September 23, 2021 12 / 28
completely abrogate PGE2 production in vivo. These data led us to hypothesize that other
phagocytic cell subsets not effectively targeted by these cre-drivers may be producing the resid-
ual PGE2, such as marginal zone macrophages (MZMs), metallophilic macrophages, or other
CD11b+ cells more broadly [33,34]. To test this hypothesis, we utilized short-term clodronate
liposomes to rapidly deplete phagocyte populations in the spleen. Mice were depleted with clo-
dronate liposomes 24 hours prior to immunization with L. monocytogenes[35]. Twelve hours
post-immunization, spleens were harvested and assessed for PGE2 by mass spectrometry.
Additionally, splenocytes were assessed for CD11b+ and CD11c+ populations by flow cytome-
try to confirm clodronate efficacy. Clodronate treatment led to significantly fewer CD11b+
cells and a trend for decreased CD11c+ cells (S6A and S6B Fig). Treatment of mice with clo-
dronate prior to infection with L. monocytogenes completely eliminated PGE2 production
compared to infected control mice (Fig 5A). Importantly, bacterial burdens were equivalent
between clodronate and mock-treated mice (Fig 5B). Pretreatment with a control empty lipo-
some, encapsome, actually increased PGE2 production compared to infected control mice,
potentially due to increased bacterial burdens (Fig 5A and 5B). To ensure that the abrogated
PGE2 was due to phagocyte depletion and not due to overall increased levels of cell death asso-
ciated with clodronate-mediated depletion, additional mice were treated with a B cell-deplet-
ing anti-CD20 antibody 24 hours prior to infection with L. monocytogenes. Treatment with
anti-CD20 resulted in depletion of ~50% of splenic B-cells, yet did not alter PGE2 production
compared to mice treated with an isotype control (S6C and S6D Fig). These data suggest that
the loss of PGE2 production in the context of clodronate treatment was specific to depletion of
phagocytes and that generic immune cell depletion and associated cell death does not prevent
PGE2 production. Taken together, these data demonstrate that phagocytic cell populations are
critical for PGE2 production in vivo following L. monocytogenes immunization.
Loss of antigen presenting cells through clodronate treatment leads to impaired CD8+ T-
cell activation due to loss of antigen presenting cells, making analysis of CD8+ T-cell responses
in this model not informative [36,37]. Given this, we alternatively assessed the possibility that
other phagocytic cells targeted by clodronate, but not the COX-2fl/fl Lyz2-cre+, could contrib-
ute to PGE2 production. Complete elimination of PGE2 production with clodronate treatment
suggested that the residual PGE2 in the COX-2
fl/fl CD11c-cre+ Lyz2-cre+ mice was due to a
phagocytic cell that was not effectively targeted in these mice. Previous data showed that
although the Lyz2-cre used in this study is highly efficient at deletion of loxP flanked genes in
some macrophage subsets, it is only minimally successful at deleting genes of interest in other
subsets, such as MZMs [33]. MZMs, characterized by expression of MARCO, are heavily
infected early in L. monocytogenes infection [22]. We hypothesized that the residual PGE2 we
detected in the COX-2fl/fl CD11c-cre+ Lyz2-cre+ mice may be due to inefficient deletion in
macrophage subsets such as these. To assess the role of MZMs in PGE2 production, we
assessed expression of COX-2 by immunohistochemistry. Mice were immunized with 107 vac-
cine strain of L. monocytogenes and spleens were harvested three and ten hours later. Spleen
cryosections were then stained for L. monocytogenes, COX-2, and MARCO. Uninfected mice
had COX-2 staining in the periarteriolar lymphoid sheath (PALS) with little expression in the
marginal zone (MZ) (Fig 5C and 5D). As early as three hours post-immunization COX-2
staining was observed in the MZ, with approximately 50% of COX-2 colocalizing with
MARCO+ cells (Fig 5C and 5D). Expression of COX-2 in the MZ was maintained at 10hpi,
again showing approximately 50% colocalization with MARCO (Fig 5C and 5D). Further-
more, L. monocytogenes colocalized with COX-2 and MARCO expressing cells, suggesting that
infected MZMs may be producing PGE2 (Fig 5D). Expression of COX-2 suggests that MZMs,
or other non-CD11c/Lyz2 expressing phagocytes within the marginal zone, could be capable
of producing PGE2 in vivo and may be contributing to the PGE2 remaining in the COX-2fl/fl
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CD11c-cre+ Lyz2-cre+ mice. To test the hypothesis that MZMs could contribute to the residual
PGE2 observed in the double transgenic mice, we assessed expression of COX-2 by immuno-
histochemistry in the COX-2fl/fl CD11c-cre+ Lyz2-cre+ mice. The mice were infected with 107
LADD L. monocytogenes or mock-infected with PBS and spleens were harvested 10 hours
later. COX-2 expression in the PALS was completely eliminated, confirming the efficacy of the
Lyz-cre and CD11-cre in deletion of COX-2 (S6E Fig). Importantly, COX-2 expression was
still detected in the MZ and colocalized with MARCO, supporting the hypothesis that MZMs
may contribute to the residual PGE2 (S6E Fig). Taken together, our data suggest that multiple
myeloid derived subsets can contribute to PGE2 production, including Lyz2
+ cells, CD11c+
cells, and possibly MZMs. Complete reductions in PGE2 by depletion of phagocytic cells such
as these with clodronate treatment is consistent with our data showing that PGE2 is produced
from phagocytic cells infected with cytosolic L. monocytogenes.
Discussion
Cytosolic access is required to effectively generate cell-mediated immunity to L. monocyto-
genes[10–12]. Decades of work has focused on understanding the cytosol-dependent processes
necessary for T-cell priming, a topic that has gained interest recently due to use of L.monocyto-
genes as a cancer immunotherapy platform. Our data suggest that one reason cytosolic access
is important may be to facilitate phagocyte production of PGE2, an eicosanoid required to gen-
erate optimal CD8+ T-cell responses [16]. We showed that PGE2 is produced by BMDMs and
BMDCs ex vivo. Importantly, this pathway is potentiated by cytosolic access, as vacuole-con-
strained L. monocytogenes induce lower production of PGE2. Furthermore, infection of mice
with a vacuole-constrained L. monocytogenes strain led to no increase of PGE2 over mock
immunized controls. Lastly, we showed that Lyz2+ and CD11c+ cells contribute to PGE2 pro-
duction in vivo as deletion of COX-2 in these subsets led to decreased PGE2 levels, however
other clodronate-sensitive phagocyte populations also contribute to PGE2 production follow-
ing L. monocytogenes immunization. This work leads to many new questions including how
cytosolic L. monocytogenes activates this pathway, how immune cells discriminate which eicos-
anoid to produce in response to infection, how even small concentrations of PGE2 still lead to
productive PGE2 responses, and how PGE2 facilitates optimal T-cell priming.
One intriguing hypothesis is that PGE2 synthesis during L. monocytogenes infection is
driven by an innate cytosolic sensor. L. monocytogenes elicits a number of innate pathways that
could contribute to differential activation of the PGE2-synthesis pathway. One possibility is
that induction of type I IFN influences PGE2 production. Type I IFN can be induced cytosoli-
cally by L. monocytogenes through recognition of cyclic diadenosine monophosphate (c-di-
AMP). Upon entry into the cytosol, L. monocytogenes secretes c-di-AMP through multidrug
resistance transporters [28,38] where it is recognized by either the reductase controlling NF-
κB (RECON) [39] or stimulator of IFN genes (STING) [40,41]. STING activation leads to type
I interferon induction [40,41], and was originally hypothesized to be critical for T-cell
Fig 5. Phagocyte depletion eliminates PGE2 production. C57BL/6 mice were dosed with 200μL clodronate, liposome
control (encapsome), or PBS 24 hours prior to immunization with 107 LADD L. monocytogenes. 12hpi spleens were
harvested and assessed for PGE2 by mass spectrometry. Data was normalized to d-PGE2 levels and percent change is
compared to L. monocytogenes-infected controls (A). Livers were harvested concurrently and assessed for bacterial
burdens (B). C57BL/6 mice were immunized with 107 LADD L. monocytogenes. 3 and 10hpi spleens were harvested,
cryosections were cut, and sections were stained for L. monocytogenes (Lm), COX-2, and MARCO (C). Yellow arrows
represent colocalization of L. monocytogenes, COX-2, and MARCO (C). Colocalization coefficients (Pearson’s
correlation) of COX-2 and MARCO were calculated (D). Data shown are representative of at least two independent
experiments. Significance was determined by a one-way ANOVA with Bonferroni’s correction (A) or a Mann-Whitney
U test (D). �p< 0.05, ��p< 0.01, ����p< 0.0001.
https://doi.org/10.1371/journal.ppat.1009493.g005
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responses. Paradoxically, however, type I IFN inhibits cell-mediated immunity to L. monocyto-
genes [14]. Interestingly, there has been well documented crosstalk between the PGE2 and type
I IFN pathways during infections with other pathogens such as influenza and M. tuberculosis
[26,27]. In the context of influenza, Coulombe et al. showed that infection led to upregulation
of PGE2 and a subsequent decrease in type I IFN [26]. In contrast to L. monocytogenes, type I
IFN is important in generating cell-mediated immune responses to influenza. Accordingly,
diminished type I IFN due to increased PGE2 reduces both acute and protective immunity
during influenza infection. On the other hand, Mayer-Barber et al. recently showed that inhi-
bition of type I IFN during M. tuberculosis infection led to an increased level of PGE2 in an IL-
1-dependent manner [27]. This correlated with better bacterial control. Due to crosstalk
between these two pathways, it seems possible that recognition of c-di-AMP and subsequently
upregulation of type I IFN may also be playing a role in PGE2 production during L. monocyto-
genes immunization. Here, we show a preliminary analysis of the role of type I IFN on PGE2
production during L.monocytogenes infection. In an ex vivomodel, strains of L.monocytogenes
that alter type I IFN levels did not change PGE2 production, suggesting that perhaps type I
IFN does not regulate PGE2. Despite these ex vivo findings, future in vivo analysis of PGE2 lev-
els in mice deficient in STING or the type I IFN receptor (IFNAR) is necessary to conclusively
define links between these two pathways. Should type I IFN negatively influence PGE2 produc-
tion in vivo, use of L. monocytogenes strains that have reduced secretion of c-di-AMP and sub-
sequently less type I IFN could be an avenue of further research for immunotherapeutic
platforms.
Another cytosolic pathway that may influence PGE2 levels during L. monocytogenes infec-
tion is the inflammasome. Inflammasomes are multiprotein complexes that recognize a wide
range of pathogen associated molecular patterns [42–44]. Wild-type L. monocytogenes infec-
tion leads to a small amount of inflammasome activation, largely through the absent in mela-
noma 2 (AIM2) inflammasome [45]. The AIM2 inflammasome recognizes cytosolic DNA that
is released during bacteriolysis within the cytosol [45–47]. Originally, inflammasomes such as
AIM2 were known to have two major downstream effects, the release of proinflammatory
cytokines IL1β/IL-18 and the induction of a lytic form of cell death, pyroptosis, characterized
by formation of membrane pores by the protein Gasdermin D [48–50]. Seminal work by von
Moltke et al. introduced a new downstream effect, the activation of an eicosanoid storm,
including PGE2 [25]. This work, as well as supporting recent work, showed elevated levels of
PGE2 after inflammasome activation [25,51]. One possible hypothesis stemming from this
work is that induction of membrane pores during pyroptosis leads to calcium influx, activating
cPLA2 and releasing arachidonic acid from the membrane. This model would suggest that use
of mice deficient in caspase-1 or Gasdermin D would lead to lower levels of PGE2 production.
Intriguingly, our ex vivo data suggest the opposite during L. monocytogenes infection. During
infection with a strain of L. monocytogenes that hyperactivates the inflammasome we found a
slight, but reproducibly significant decrease in PGE2 production. We hypothesize that this is
likely due to increased pyroptosis in host cells, leading to a lower number of viable cells able to
produce PGE2. Alternatively, the diminished PGE2 could be due to crosstalk between these
two pathways. This finding is consistent with other data showing that hyperactivation of the
inflammasome leads to impaired cell-mediated immune responses [6,52], leading to the possi-
bility that one reason for impaired responses in the context of robust inflammasome activation
may be due to lower PGE2. Further analysis of PGE2 levels in vivo during hyper-inflammasome
activation and/or in mice lacking inflammasome components will be important to elucidate
these details. The role of inflammasomes as well as type I IFN are intriguing avenues to under-
stand signaling pathways driving PGE2 production during L. monocytogenes infection.
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It is also possible that production of PGE2 by L. monocytogenes is independent of known
cytosolic pathways. Identification of other unknown censors could be accomplished by assess-
ing PGE2 levels in response to different L. monocytogenes mutants. Mutant strains of L. mono-
cytogenes that differentially induce PGE2 could provide insight as to the cytosolic censors
involved. One additional hypothesis is that PGE2-production is independent of a cytosolic sen-
sor completely and instead is driven by LLO-mediated pore formation. Though LLO is tightly
regulated transcriptionally, translationally, and posttranslationally to be most active in the vac-
uole, a small amount of LLO may remain active in the cytosol of cells [53–55]. It is possible
that this small amount of LLO induces pore formation in the cell membrane and allows cal-
cium influx, subsequently activating cPLA2. Use of strains that further restrict LLO production
in the cytosol, such as new strains that excise hly once L. monocytogenes has entered the cytosol
[56], could help assess the role of LLO-mediated pores on PGE2 production.
In addition, our data show an interesting phenotype where BMDCs and PAM-primed
BMDMs selectively produce PGE2 in response to L. monocytogenes infection rather than a
global increase in eicosanoid production. Analysis of the eicosanoid milieu in cell culture
supernatant show an increase in PGE2 production during wild-type L. monocytogenes infec-
tion, but little to no changes in other eicosanoids such as PGD2, TXB2, or LTB4. This raises the
question of how a cell determines which eicosanoid to produce in response to different stimuli.
The eicosanoid produced in different conditions is dependent on terminal synthases [21].
Therefore, the expression and activity of these synthases determine the resulting eicosanoid
milieu. Multiple factors impact expression of different synthases including cytokines, hor-
mones, and microbial products [57]. For example, expression of mPGES-1 can be induced by
LPS and prostaglandin D2 synthases, though less well understood, can be upregulated by glu-
cocorticoids [58–60]. Conversely, anti-inflammatory cytokines such as IL-10 can inhibit
expression of mPGES-1 [61]. Given that vacuole constrained L. monocytogenes have previously
been demonstrated to induce high levels of IL-10 leading to inhibition of T-cell priming, it is
interesting to speculate that the inhibition of PGE2 production observed in our co-infection
experiments could be tied to this previously observed induction of IL-10. Use of other L.mono-
cytogenes strains that differentially activate cytokines or are deficient in different microbial
PAMPs could be informative as to which signal specifically leads to enhanced levels of
mPGES-1 transcript. In addition, activity of each synthase also may dictate which eicosanoids
are produced [57]. Terminal synthase activity can be modulated by posttranslational modifica-
tion (such as phosphorylation) as well as presence of cofactors (such as ATP and glutathione)
[57]. Depletion of essential cofactors during metabolic or oxidative stress could influence the
induced inflammatory milieu [57]. The post transcriptional regulation highlights the necessity
of assessing endpoint eicosanoid production rather than simply transcript or protein levels, as
these other factors influencing activity can alter which eicosanoids ultimately are produced.
This is particularly true in our data, as despite seeing upregulation of mPGES-1 transcript dur-
ing infection of unprimed BMDMs and BMDCs, we failed to see PGE2 production. This sug-
gests that perhaps some additional modification is necessary to induce mPGES-1 activity
during L. monocytogenes infection. Similarly, our data suggest that cytosolic access is not
required for COX-2 translation in primed BMDMs, but is required to fully induce PGE2 pro-
duction. This again suggests that further modification of COX-2 may be important for optimal
activity. In contrast, cytosolic access is required for both COX-2 protein translation and PGE2
production in BMDCs. Perhaps PGE2 production in BMDCs is driven by COX-2 protein
expression, whereas in BMDMs it is driven by post translational modifications. Further analy-
sis on the role of phosphorylation and cofactor availability will help elucidate these details of
regulation.
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Another pressing question generated from this work is how productive T-cell responses
were induced in mice deficient in COX-2 in both CD11c+ and Lyz2+ cells despite reduced
PGE2 levels. Here, we show that these mice produce substantially reduced PGE2, yet still
induce wild-type CD8+ T-cell responses. One hypothesis that we explored in this work is that
other cell subsets not efficiently targeted by our cre/lox model were still producing PGE2. Cer-
tain cell subsets such as MZMs do not have effective gene deletion using the Lyz2+ promoter
to drive cre recombinase expression [33]. Our immunohistochemistry data suggest that
MZMs still may be capable of producing PGE2 in the COX-2
fl/fl CD11c-cre+ Lyz2-cre+ mice
(S6D Fig). For this reason, we hypothesized that subsets such as these may still be producing
sufficient levels of PGE2 to drive T-cell responses. One way to assess the role of MARCO
+
MZMs is use of a new cre recombinase-driving promoter, SIGN-R1, developed by Pirgova
et al [34]. SIGN-R1 is a lectin binding receptor expressed on MZMs and drives more efficient
deletion of genes by the cre/lox system [34]. Generation of triple COX-2 knockout mice that
express the SIGN-R1-cre in combination with our reported COX-2fl/fl Lyz2-cre+ CD11c-cre+
model could be informative about the role of MZMs in production of PGE2. Though we show
that Lyz2+ and CD11c+ cells contribute to PGE2, analysis of MZMs and other myeloid cells
will further understanding of PGE2 production.
The lack of diminished cell-mediated immunity could also be due to local acting effects of
PGE2. It is possible that even if PGE2 levels are below detection at a whole spleen level, certain
cells are able to produce PGE2 locally in sufficient concentration to drive T-cell responses.
More sensitive measures of PGE2, such as quantitative mass spectrometry imaging recently
developed, would be required to analyze local responses such as these [62]. These novel tech-
niques enable analysis of location of PGE2 and other eicosanoids within a spleen and could
detect lower concentrations [62]. Similarly, the sensitivity of the receptor PGE2 is acting upon
during L. monocytogenes infection could influence how much PGE2 is necessary for inducing a
response. PGE2 binds primarily to four receptors, EP1-4 [63]. EP3 and EP4 are higher affinity
receptors (kD ~1nM compared to 10-15nM for EP1/2) [63,64]. Should the higher affinity
receptors be identified as the important receptors for influencing immunity during L. monocy-
togenes infection, even lower concentrations of PGE2 still induced in our COX-2fl/fl Lyz2-cre+
CD11c-cre+ model may be sufficient for cell-mediated responses. Further analysis as to rele-
vant receptors and which cells they are expressed on could help elucidate these details.
Lastly, how PGE2 facilitates T-cell responses in the context of L. monocytogenes immuniza-
tion remains unknown. In innate immune cells, PGE2 influences expression of co-stimulatory
and activation markers. PGE2 signaling in dendritic cells upregulates the co-stimulatory mole-
cules OX40L and 4-1BBL [65], thereby promoting T-cell proliferation. Similarly, PGE2 signal-
ing in macrophages leads to polarization towards a more inflammatory M1 phenotype [66]
and aids in activation [67]. Furthermore, PGE2 promotes migration of innate cell subsets, lead-
ing to enhanced migration towards CCL21[68,69] and MCP-1 [70,71]. These proinflammatory
functions suggest that PGE2 may be acting to enhance immunity through its local effects on
innate immune cells. PGE2 may also be influencing immunity more directly on T-cell subsets,
such as through polarization of T-cells towards a Th1 phenotype [72]. Additionally, PGE2
leads to higher expression of OX-40L, OX-40, and CD70 directly on T-cells, promoting T-cell
interactions and sustaining immune responses [65]. In order to more fully understand how
PGE2 facilitates T-cell responses to L. monocytogenes, a comprehensive analysis of these effects
on both T-cells and innate immune cells is required.
We and others have shown that innate immune responses substantially influence cell-medi-
ated immune responses, particularly the inflammatory milieu induced during infection. Here,
we present evidence that one pathway critical for immunity, induction of PGE2, is dependent
on access to the cytosol. Furthermore, we show that PGE2 is produced by macrophages and
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dendritic cells. These data suggest analysis and modulation of eicosanoid levels, particularly




This work was carried out in strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of Health. All protocols were
reviewed and approved by the University of Wisconsin-Madison Institutional Animal Care
and Use Committee.
Bacterial strains
The Listeria monocytogenes strains used in this study were all in the 10403s background. The
attenuated (LADD) strain used in the analysis of T-cell responses was in the ΔactAΔinlB back-
ground as previously described and engineered to express full length OVA and the B8R20-27 epi-
tope [30]. OVA and B8R20-27 were constructed as a fusion protein under the control of the actA
promoter with the secretion signal of the amino terminal 300bp of the ActA gene [15]. This
fusion protein was integrated into the site-specific pPL2e vector as previously described [15].
Mouse strains
Six- to eight-week-old C57BL/6 male and female mice were obtained from the NCI and
Charles River NCI facility. Ptgs2-/- (COX-2-/-) mice were obtained from Jackson Laboratory
and maintained as heterozygote breeding pairs. Ptges-/- (mPGES1-/-) mice lacking microsomal
PGE synthase have been previously described [73–75]. In order to generate cell-type specific
COX-2 knockout mice, COX-2fl/fl mice (stock number 030785) were obtained from Jackson
Laboratory and crossed with Lyz2-cre (stock number 004781), CD11c-cre (stock number
008068), or CD4-cre expressing mice (stock number 022071), all also obtained from Jackson
Laboratory. Double Lyz2-cre and CD11c-cre expressing mice were generated by crossing
COX-2fl/fl Lyz2-cre+ mice with COX-2fl/fl CD11c-cre+ mice. Genotypes were confirmed by
PCR using the primer pairs in Table 1. In experiments assessing PGE2 production and T-cell
responses in these mice, COX-2flf/l cre- mice were used as controls for initial experiments, fol-
lowed by duplicate experiments using either COX-2flf/l cre- or WT C57BL/6 mice. Experiments
utilizing COX-2fl/fl cre- mice or C57BL/6 mice induced consistent PGE2 levels and T-cell
responses, suggesting that insertion of the loxP site independently did not influence COX-2
expression.
Table 1. Genotyping primers.
Mouse genotype Forward (5’-3’) Reverse (5’-3’)
COX-2fl/fl AAT TAC TGC TGA AGC CCA CC CTT CCC AGC TTT TGT AAC CAT
CD4-cre GAACC TGATG GACAT GTTCA GG
(cre specific)
AGTGC GTTCG AACGC TAGAG CCTGT
(cre specific)
TTACG TCCAT CGTGG ACAGC
(internal control)
TGGGC TGGGT GTTAG CCTTA
(internal control)
CD11c-cre ACT TGG CAG CTG TCT CCA AG
(cre specific)
GCG AAC ATC TTC AGG TTC TG
(cre specific)
CAA ATG TTG CTT GTC TGG TG
(internal control)
GTC AGT CGA GTG CAC AGT TT
(internal control)
Lyz2-cre CCC AGA AAT GCC AGA TTA CG CTT GGG CTG CCA GAA TTT CTC
https://doi.org/10.1371/journal.ppat.1009493.t001
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BMDM and BMDC generation and infection
Bone marrow-derived macrophages and dendritic cells were made using six- to eight-week-
old Ptgs2-/- (COX-2-/-) or C57BL/6 mice as previously described [15,76]. Briefly, bone marrow
was harvested and macrophages were cultured in the presence of M-CSF from transfected 3T3
cell supernatant for six days with a supplement of M-CSF at day three and frozen down for
storage. Dendritic cells were cultured in the presence of 20ng/ml recombinant GM-CSF (BD
Biosciences, San Jose, CA) for 7 days with a supplement of 20ng/mL GM-CSF every third day.
For infection, BMDMs or BMDCs were plated at 1x106 cells/well in a 12 well dish overnight
+/- 100ng/mL PAM3CSK4. The following morning, cells were infected with indicated strains
of L. monocytogenes or PBS control at an MOI of 10 unless otherwise indicated. Thirty minutes
later, supernatant was removed and replaced with medium containing 50μg/mL gentamycin
to remove extracellular bacteria. At the indicated times, cells were harvested for western blot
or qRT PCR and supernatant was harvested for eicosanoid analysis as described below.
qRT PCR
RNA was isolated from BMDMs or BMDCs using the RNAqueous-Micro Total RNA Isolation
Kit (Invitrogen), and DNAse treated with Turbo DNAse (Invitrogen) according to manufac-
turer’s instructions. 500ng total RNA was reverse transcribed in 10μL reactions using the
iScript cDNA Synthesis Kit (BioRad) according to manufacturer’s instructions and cDNA was
diluted 10-fold using molecular grade water (Invitrogen). 2.5μL diluted cDNA was used as
template in a 10μL qRT-PCR reaction performed in duplicate using gene-specific primers and
Kapa SYBR Green Universal qPCR mix (KAPA Biosystems) according to manufacturer’s
instructions using a BioRad CFX Connect Real-Time PCR System. The sequences of gene-spe-
cific primers are shown in Table 2. Data was analyzed using Excel and all RNA abundances
were calculated by using a standard curve of synthesized template (Integrated DNA Technolo-
gies, G-Blocks) and are normalized to ActB (β-actin).
Western blots
BMDMs or BMDCs were harvested and protein was extracted using the Pierce SDS-PAGE
Sample Prep Kit (Thermo) according to the manufacturer’s instructions. Total protein content
was measured by the Pierce BCA Protein Assay Kit (Thermo) and equivalent protein levels
were loaded into a polyacrylamide gel (BioRad). Samples were transferred onto a nitrocellulose
membrane using a semi-dry transfer apparatus before blocking with a 5% skim milk solution
for thirty minutes at room temperature. After washing 3x with PBS-T, the membrane was
incubated overnight at 4˚C with the primary antibodies anti-COX-2 (1:200, Cayman Chemi-
cal) and anti-β-actin loading control (1:1000, ThermoFisher) in a 5% bovine serum albumin
solution. The following day samples were washed with PBS-T before being incubated with sec-
ondary antibodies (anti-rabbit 800 at 1:10,000, anti-mouse 680 at 1:5,000). Samples were
Table 2. qRT PCR primers.
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imaged on a LiCor imager and analyzed via ImageStudio. Sample signal was normalized to β-
actin and relative abundance was compared to wild-type L. monocytogenes.
In vivo immunizations and pharmacological treatments
L.monocytogenes of the wild-type, attenuated (LADD), or Δhly background were grown overnight
in brain heart infusion media at 30C. The bacteria were back diluted 1:5 and allowed to grow to
log phase (OD0.4–0.6, ~1–1.5 hours) at 37C, with aeration, prior to infection. Bacteria were
diluted in PBS and mice were infected with 200μL at the indicated doses intravenously. For bacte-
rial burden analysis, mice were sacrificed at 12hpi and livers were homogenized in 0.1% Nonidet
P-40 in PBS and plated on Luria-Bertani plates. For splenic macrophage depletion, 200μL clodro-
nate, PBS control, or endosome lipid control (Encapsula Nano Sciences) were given intravenously
24 hours prior to bacterial infection according to the manufacturer’s instructions. For B-cell
depletion, mice were dosed intraperitoneally with 12.5μg of Ultra-LEAF Purified anti-mouse
CD20 (clone SA271G2) or isotype control (clone RTK4530) in 100μL PBS 24 hours prior to bacte-
rial infection. Depletion efficacy of relevant cell subsets was confirmed by assessing abundance of
splenic CD11b+ cells (clone M1/70), CD11c+ cells (clone N418), or B220+ cells (clone RA3-6B2)
by flow cytometry. Celecoxib (Cayman Chemical) was milled into standard mouse chow (Envigo)
at 100mg/kg and fed ad lib for 48 hours before and after immunization [16,77].
Eicosanoid measurement
In vivo eicosanoid levels were assessed by mass spectrometry. Ex vivo analysis was assessed by
mass spectrometry or ELISA, as indicated. For ex vivo PGE2 analysis by ELISA, BMDMs were
plated and infected as described above. Supernatant was harvested at indicated timepoints and
diluted 1:100 in ELISA buffer (Cayman Chemical). PGE2 was detected using a PGE2 ELISA kit
(Cayman Chemical) following the manufacturer’s instructions. For mass spectrometry eicosa-
noid extractions, spleens from mice were harvested at twelve hours post immunization and
flash frozen in tubes containing 50ng deuterated PGE2 standard (Cayman Chemical) in 5μL
methanol and stored overnight at -80C. For ex vivo extractions, 1mL of supernatant was flash
frozen in tubes similarly containing 50ng deuterated PGE2 standard in 5μL methanol. The fol-
lowing day, two mL of ice cold methanol were added to the tissue culture supernatant or
spleens. Spleens were homogenized in glass homogenizers. Samples then were incubated at 4C
for 30 minutes. Next, cellular debris was removed by centrifugation and samples were concen-
trated to 1mL volume before being acidified with pH 3.5 water and loaded onto conditioned
solid phase C18 cartridges. Samples were washed with hexanes before eluting using methyl for-
mate followed by methanol. Samples were concentrated using a steady stream of nitrogen gas
and suspended into 55:45:0.1 MeOH:H2O:acetic acid and analyzed on an HPLC coupled to a
mass spectrometer (Q Exactive; Thermo Scientific) using a C18 Acquity BEH column (100mm
x 2.1 mm x 1.7μm) operated in negative ionization mode. Samples were eluted with a mobile
phase 55:45:0.1 MeOH:H2O:acetic acid shifted to 98:2:0.1 over 20 minutes. Mass-to-charge
ratios included were between 100 and 800 and compared to standards (Cayman Chemical) by
analysis via MAVEN [78,79]. Samples were normalized to deuterated PGE2 levels to ensure
that differences between samples was not due to extraction efficiency. Average PGE2 ion count
for each sample was then compared to PBS or WT infected samples, as indicated.
T-cell analysis
Mice were sacrificed seven days after immunization and splenocytes were isolated as previ-
ously described [6]. In brief, red blood cells were lysed using ACK buffer and then splenocytes
were counted using a Z1 Coulter counter. For tetramer analysis, splenocytes were immediately
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blocked for Fc (Tonbo Bioscience) and stained for B8R tetramer (AF488, 1:300, NIH Tetramer
Facility, Atlanta, GA) followed by staining with anti-CD3 (PeCy7, 1:100, clone 145-2C11) and
anti-CD8α (eFlour450, 1:200, clone 145-2C11). Cells were then stored overnight at 4C in a 1:1
of IC Fixation Buffer (ThermoFisher Scientific) and FACS buffer. For analysis of cytokine pro-
duction, 1.7x106 cells were plated in a 96 well dish and incubated for five hours in the presence
of B8R20-27 (TSYKFESV) or OVA257-264 (SIINFEKL) peptides and brefeldin A (eBioscience).
Splenocytes were then subjected to FC block (Tonbo Bioscience) and stained with anti-CD3
(FITC, 1:200, clone 145-2C11) and anti-CD8α (eFlour450, 1:200, clone 53–6.7) before treat-
ment with fixing and permeabilization buffers (eBioscience). Cells were then further stained
with anti-IFNγ (APC, 1:300, clone XMG1.2). Samples were acquired using the LSRII flow
cytometer (BD Biosciences, San Jose, CA) and analyzed with FlowJo software (Tree Star, Ash-
land, OR).
Cryosection preparation and immunofluorescence microscopy of infected
spleens
C57BL/6 or COX-2fl/fl CD11c-cre+ Lyz2-cre+ mice were infected intravenously by tail vein
injection of 107 LADD L. monocytogenes in 150 μl of PBS. Mice were sacrificed at 3 or 10 hpi
and spleens harvested and snap frozen in OCT for immunofluorescence microscopy as
described previously [22]. Uninfected mice were used as negative controls. Briefly, 5μm spleen
cryosections were cut using a Leica CM1850 cryostat, mounted on Superfrost Plus microscope
slides (Thermo Fisher) and stored at -80˚C until use. Slides were fixed in 10% buffered forma-
lin phosphate at RT for 5 minutes and sections, washed in TBS and blocked with StartingBlock
T20 Blocking buffer containing Fc blocker (Thermo Scientific, 37543). Sections were incu-
bated with unconjugated L. monocytogenes monoclonal Ab (Invitrogen, MA1-20271), anti-
MARCO polyclonal Goat IgG-Biotin (R&D Systems, BAF2956), and FITC-conjugated COX2
polyclonal antibody (Cayman Chemical, 10010096) at 1/100-200 dilution at RT for 1-2h in
dark humidified incubation chamber or isotype control antibodies including Rabbit IgG-FITC
(Invitrogen, 11-4614-80), Armenian Hamter IgG-PE (Invitrogen, 13-4888-81) and Mouse
IgG2a kappa (Invitrogen, 14-4724-81). Biotinylated and unconjugated primary antibodies
were detected by incubating with Streptavidin-PE (Pharmingen, 534061) and Rat anti-mouse
IgG2a antibody (Invitrogen, 17-4210-80) respectively. Slides were preserved using ProLong
Diamond Antifade mounting media (Invitrogen, P36965) and clear nail polish to seal the
edges. Slides were analyzed using an Olympus IX51 fluorescence microscope equipped with
LCPlanFL 20x/0.4 NA and UPlanFL 40x/1.3 oil objectives, an X-Cite 120 excitation unit
(Exfo), FITC/PE/APC optimized filter sets (Semrock), an Orca Flash 2.8 monochrome camera
(Hamamatsu) and SlideBook software (Intelligent Imaging Innovations) for hardware control
and image acquisition. Images were captured with both 20x an 40x objective with exposure
times ranging from 200-400ms. Pseudo-colored 3-channel RGB mages were imported into
Imaris 9.6 (Bitplane) for smoothing, contrast enhancement (linear contrast stretch), annota-
tion and colocalization analysis.
Statistical analysis
Statistical analysis was performed by GraphPad Prism Software (La Jolla, CA) and analyzed via
Mann Whitney U test or one-way ANOVA with Bonferroni’s correction as indicated.
Supporting information
S1 Fig. Infection or priming of BMDMs and BMDCs does not alter cPLA2 transcript
expression. Activation of type I IFN or inflammasomes does not substantially alter PGE2
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production. BMDMs or BMDCs were infected with the indicated strains of L. monocytogenes
at an MOI 10 +/- the TLR2 agonist PAM3CSK4 and assessed 6hpi for the expression of
Pla2g4a (encoding cPLA2, A), Ifnb1 (encoding interferon β, B), and Il1b (encoding IL-1β, C)
by qRT PCR. PAM3CSK4-primed BMDMs were infected at an MOI 10 for six hours (unless
otherwise specified) with the indicated strains of L. monocytogenes. PGE2 levels in the superna-
tant was then assessed by ELISA (D-F). Data are a combination of three independent experi-
ments. Significance was determined by a one-way ANOVA with Bonferroni’s correction.
�p< 0.05, ��p< 0.01, ���p< 0.001, ����p< 0.0001.
(TIF)
S2 Fig. Infection of BMDMs or BMDCs with L. monocytogenes does not lead to a global
increase in eicosanoid production. Wild-type or COX-2-/- BMDMs (A) or BMDCs (B) were
infected with the indicated strains of L. monocytogenes at an MOI of 10 +/- the TLR2 agonist
PAM3CSK4. Supernatant was harvested 6hpi and assessed for prostaglandin D2 (PGD2),
thromboxane B2 (TXB2), or leukotriene B4 (LTB4). Data was normalized to d-PGE2 and fold
change is relative to PBS treated controls. Data are a combination of two independent experi-
ments. Significance was determined by a one-way ANOVA with Bonferroni’s correction.
�p< 0.05.
(TIF)
S3 Fig. COX-2 deletion in CD4+ cells does not alter PGE2 production. Indicated strains of
mice were immunized with 107 LADD L. monocytogenes or PBS control. 12hpi spleens were
harvested and assessed for PGE2 by mass spectrometry. Data was normalized to d-PGE2 levels
and fold change is compared to PBS controls. Data are representative of two independent
experiments. Significance was determined by a one-way ANOVA with Bonferroni’s correc-
tion.
(TIF)
S4 Fig. COX-2 deletion in CD11c+ or Lyz2+ does not impair T-cell responses. Indicated
strains of mice were infected with 107 LADD L. monocytogenes. 7dpi splenocytes were exam-
ined for OVA-specific CD8+ T-cell responses. %IFNγ (A) or number IFNγ (B) per spleen was
assessed. B8R-tetramer positive CD8+ T-cell responses were also assessed (C). Data are a repre-
sentative of two independent experiments of 4–5 mice per group. Significance was determined
by a Mann-Whitney U test.
(TIF)
S5 Fig. COX-2 deletion in both CD11c+ and Lyz2+ does not impair T-cell responses. Indi-
cated strains of mice were infected with 107 LADD L. monocytogenes. 7dpi splenocytes were
examined for OVA-specific CD8+ T-cell responses. %IFNγ (A) or number IFNγ (B) per spleen
was assessed. B8R-tetramer positive CD8+ T-cell responses were also assessed (C). Data shown
are representative of two independent experiments of 3–5 mice per group. Significance was
determined by a Mann-Whitney U test (B-C). �p< 0.05.
(TIF)
S6 Fig. Clodronate treatments reduces CD11b+ and slightly reduces CD11c+ populations
in the spleen. Anti-CD20 treatment depletes splenic B220+ cells, but does not influence
PGE2 production. C57BL/6 mice were dosed with 200μL clodronate, liposome control (encap-
some), or PBS 24 hours prior to immunization with 107 LADD L. monocytogenes. 12hpi
spleens were harvested and assessed for CD11b+ (A) and CD11c+ (B) populations by flow
cytometry. C57BL/6 mice were dosed with 50μg anti-CD20 or isotype control 24 hours prior
to immunization with 107 LADD L. monocytogenes. 12hpi spleens were harvested and assessed
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for B220+ populations by flow cytometry (C) or PGE2 levels by mass spectrometry (D). COX-
2fl/fl CD11c-cre+ Lyz2-cre+ were infected with 107 LADD L. monocytogenes. 10hpi spleens
were harvested, cryosections were cut, and sections were stained for L. monocytogenes, COX-2,
and MARCO (E). Data shown are a combination of two independent experiments. Signifi-
cance was determined by a Mann-Whitney U test. �p< 0.05, ��p< 0.01.
(TIF)
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63. Markovič T, Jakopin Ž, Dolenc MS, Mlinarič-Raščan I. Structural features of subtype-selective EP
receptor modulators. Drug Discov Today. 2017 Jan 1; 22(1):57–71. https://doi.org/10.1016/j.drudis.
2016.08.003 PMID: 27506873
64. Abramovitz M, Adam M, Boie Y, Carrière M-C, Denis D, Godbout C, et al. The utilization of recombinant
prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs.
Biochim Biophys Acta. 2000 Jan 17; 1483(2):285–93. https://doi.org/10.1016/s1388-1981(99)00164-x
PMID: 10634944
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